Bespoke Extracts, Inc.

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:30:00 2024-07-05 EDT			5-day change	1st Jan Change
0.088 ^USD	0.00%		+7.32%	+147.89%

07-02	Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-18	Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

July 02, 2024 at 06:04 am

Bespoke Extracts, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.260428 million compared to USD 0.089016 million a year ago. Net loss was USD 0.314118 million compared to USD 0.44062 million a year ago.

Basic loss per share from continuing operations was USD 0.03 compared to USD 0.04 a year ago.

Latest news about Bespoke Extracts, Inc.

Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07-02	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-18	CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding	02-15	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01-16	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-28	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-07-14	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	23-04-26	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.	22-08-11	CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors	22-06-29	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors	22-05-22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	22-03-24	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	22-03-24	CI
Bespoke Extracts, Inc. Changes Fiscal Year from August 31 to December 31	22-02-04	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	22-01-19	CI
Bespoke Extracts, Inc. announced that it has received $0.25 million in funding	21-12-30	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.25 million in funding	21-12-26	CI
Bespoke Extracts, Inc. Announces Appointment of Hunter Garth as President	21-12-15	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	21-12-13	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	21-12-12	CI
Bespoke Extracts, Inc. agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.	21-12-01	CI
Infinity Management LLC completed the acquisition of 20.1% stake in Bespoke Extracts, Inc. from Danil Pollack.	21-11-18	CI

Chart Bespoke Extracts, Inc.

Duration

Period

More charts

Company Profile

Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BESPOKE EXTRACTS, INC.	+147.89%	895K
ELI LILLY AND COMPANY	+56.89%	823B
NOVO NORDISK A/S	+39.52%	627B
JOHNSON & JOHNSON	-6.55%	353B
MERCK & CO., INC.	+15.99%	320B
ABBVIE INC.	+7.92%	295B
ASTRAZENECA PLC	+13.74%	239B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	167B